Reported 639,579 shares, up 49,205 (8.3%) from the prior quarter.
Reported value -14.0%; share count 8.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 61188000 |
| 2022-03-31 | 61441000 |
| 2022-06-30 | 65571000 |
| 2022-09-30 | 81269000 |
| 2022-12-31 | 46807000 |
| 2023-03-31 | 59634000 |
| 2023-06-30 | 43167000 |
| 2023-09-30 | 0 |
| 2026-03-31 | 33629173 |
| 2026-06-30 | 48156807 |
| 2026-09-30 | 41431928 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 639,579 | +49,205 (8.3%) | 0.05% | $41,431,928 | 2026-11-12 | |
| Q2 2026 | Added | 590,374 | +96,771 (19.6%) | 0.06% | $48,156,807 | 2026-08-14 | |
| Q1 2026 | New | 493,603 | +493,603 (0.0%) | 0.05% | $33,629,173 | 2026-05-14 | |
| Q3 2023 | Reduced | 0 | -1,061,398 (-100.0%) | 0 | $0 | 2023-11-09 | |
| Q2 2023 | Reduced | 1,061,398 | -169,684 (-13.8%) | 0.07% | $43,167,000 | 2023-08-11 | |
| Q1 2023 | Added | 1,231,082 | +4,817 (0.4%) | 0.1% | $59,634,000 | 2023-05-11 | |
| Q4 2022 | Reduced | 1,226,265 | -392,629 (-24.3%) | 0.09% | $46,807,000 | 2023-02-10 | |
| Q3 2022 | Reduced | 1,618,894 | -17,941 (-1.1%) | 0.16% | $81,269,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 1,636,835 | -9,949 (-0.6%) | 0.12% | $65,571,000 | 2022-08-05 | |
| Q1 2022 | Added | 1,646,784 | +110,561 (7.2%) | 0.08% | $61,441,000 | 2022-05-13 | |
| Q4 2021 | Added | 1,536,223 | +247,968 (19.2%) | 0.07% | $61,188,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
431 managers reported PTC THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 14,397,317 | +432,763 | 0.01% | $932,658,183 | 9 qtrs |
| JANUS HENDERSON GROUP PLC | Reduced | 6,871,205 | -322,228 | 0.19% | $445,053,144 | 1 qtr |
| STATE STREET CORPORATION | Added | 5,512,555 | +913,603 | 0.01% | $357,079,668 | 53 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 5,277,697 | +1,149,424 | 0.06% | $341,889,211 | 53 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 4,978,205 | +50,094 | 0.01% | $322,488,120 | 3 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 3,618,497 | -120,630 | < 0.01% | $234,406,236 | 3 qtrs |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Added | 2,699,340 | +743,184 | 0.57% | $174,863,245 | 2 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 2,147,988 | -59,388 | < 0.01% | $139,173,677 | 53 qtrs |
| UBS Group AG | Added | 1,880,447 | +1,618,021 | 0.02% | $121,815,357 | 48 qtrs |
| Hood River Capital Management LLC | Added | 1,756,325 | +17,712 | 0.96% | $113,774,734 | 7 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 12, 2026
- Filing type
- 13F-HR
- Position type
- COMMON
Voting authority reported
- Sole
- 626,377
- Shared
- 0
- None
- 13,202
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.